Get started
Author

Sheinei Alan

Observed names: Alan Sheinei, Sheinei S Alan
OpenAlex ID: A5077173137
Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes
2024 · Sheinei Alan, Deva Sharma, et al. · Current Opinion in Hematology · 9
PDF
Advancing through challenges: current strategies in sickle cell disease management
2024 · Sheinei Alan, Sebastian R. Mendez-Marti, et al. · Annals of Blood · 6
Overcoming Challenges to Surrogate Decision Making for Young Adults at the End of Life
2021 · Nathan Lightfoot, Yordanka Kirkova, et al. · American Journal of Hospice and Palliative Medicine® · 6
Pociredir, a novel oral once-daily fetal hemoglobin inducer: Results from the Phase 1b pioneer study in adult participants with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness
2025 · Sheinei Alan, Johnny Mahlangu, et al. · Blood · 3
PDF
Advances in pharmacotherapy for sickle cell disease: what is the current state of play?
2024 · Sheinei Alan, Julie Kanter · Expert Opinion on Pharmacotherapy · 3
Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing
2024 · Sebastian R. Mendez-Marti, Chad Zik, et al. · Journal of Hematology · 3
PDF
Extramedullary Hematopoiesis in SCD Is More Prevalent Than Previously Recognized
2024 · Sheinei Alan, Najeebah Bade, et al. · Journal of sickle cell disease. · 2
PDF
The right patient, the right treatment: tailoring sickle cell disease care
2025 · Sheinei Alan, Payal Desai · Hematology · 1
Efficacy and safety of osivelotor in participants with sickle cell disease in a 12-week phase 2, multicenter, open-label, dose-finding trial and extension study
2025 · Santosh Saraf, Shehu Abdullahi, et al. · Journal of sickle cell disease. · 1
Hydroxyurea May Improve Sickle Cell Nephropathy in Adults with HbSS
2024 · Sheinei Alan, Rania Fusisi, et al. · Journal of sickle cell disease. · 1
How Sensitive Is the Sickle Prep? Clinical Implications
2023 · Sebastian R Mendez Marti, William B Ershler, et al. · Blood · 1
PDF
Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome
2022 · Chad Zik, Sheinei Alan, et al. · Blood · 1
A novel US-based grading system for disease severity in sickle cell disease: the Sickle Cell Outcome Grading System (SCOGS)
2026 · Tarun Aurora, Renee Hodges, et al. · The Lancet Haematology
Safety and efficacy of pociredir in adults with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness: results from the phase 1b PIONEER study
2026 · Sheinei S Alan, Johnny Mahlangu, et al. · Journal of sickle cell disease.
National alliance of sickle cell centers consensus recommendations for defining an adult sickle cell disease specialist
2025 · Francis Coyne, Sheinei Alan, et al. · Blood
Development of the sickle cell outcome grading system (SCOGS), a novel classification system for sickle cell disease severity
2025 · Tarun Aurora, Renee Hodges, et al. · Blood
Empowering Minds, Easing Pain: The Role of Talk Therapy in Sickle Cell Disease
2024 · Sheinei Alan, Rania Fusisi, et al. · Journal of sickle cell disease.
Ineffective Erythropoiesis with Aging in Adults with Sickle Cell Disease
2023 · Upama Giri, Alan Sheinei, et al. · Blood
PDF
Partial Red Cell Exchange Is an Effective Tool for Adequately Reducing Hemoglobin S Levels in Patients with Sickle Cell Disease and Improving Patient Outcomes Including Reduction in Acute Care Utilization
2023 · Alan Sheinei, Chad Zik, et al. · Blood
PDF
Implementation of an Adult Sickle Cell Center Directly Correlates with Improved Patient Outcomes and Decreased Acute Care Utilization
2023 · Alan Sheinei, William B Ershler, et al. · Blood
PDF
Works count: 20
Citation count: 37
H-index: 3
I10-index:
Year
Topic
Type